News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dyax Corp. (DYAX) to Participate in the Leerink Swann and Company Global Healthcare Conference


2/6/2013 6:13:21 AM

Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the Leerink Swann Global Healthcare Conference, being held February 13-14, 2013, at the Waldorf Astoria in New York City. Gustav Christensen, President and Chief Executive Officer of Dyax, will present on Thursday, February 14 at 11:00 AM (ET). Mr. Christensen will provide a corporate update regarding the Company’s key value drivers – KALBITOR® (ecallantide) and the angioedema portfolio, as well as the Licensing and Funded Research Program (LFRP).

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES